Literature DB >> 14633302

Angiogenesis in nervous system disorders.

Gelareh Zadeh1, Abhijit Guha.   

Abstract

Angiogenesis is a crucial requirement for embryonal development and new vessel formation during adult life. Various disease processes such as cancer, ischemia, vascular malformations, and inflammatory processes also depend on pathological angiogenesis. A better understanding of the complex and coordinated interactions among various angiogenic pathways involved in pathological angiogenesis is necessary to improve our therapeutic approaches to the various disease processes observed in the central nervous system. This review summarizes the current understanding of the role of principal angiogenic factors relevant to neurosurgical abnormalities.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14633302     DOI: 10.1227/01.neu.0000093425.98136.31

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  12 in total

1.  Increased expression of ephrin A1 in brain arteriovenous malformation: DNA microarray analysis.

Authors:  Atsushi Sasahara; Hidetoshi Kasuya; Hiroyuki Akagawa; Hiroshi Ujiie; Osami Kubo; Toshiyuki Sasaki; Hideaki Onda; Yoshiko Sakamoto; Boris Krischek; Tomokatsu Hori; Ituro Inoue
Journal:  Neurosurg Rev       Date:  2007-06-19       Impact factor: 3.042

Review 2.  Angiogenesis opens a way for Chinese medicine to treat stroke.

Authors:  A-li Yang; Qing-hua Liang; Han-jin Cui; Hua-jun Zhou; Jie-kun Luo; Tao Tang
Journal:  Chin J Integr Med       Date:  2013-10-30       Impact factor: 1.978

Review 3.  [Therapeutically induced arteriogenesis in the brain. A new approach for the prevention of cerebral ischemia with vascular stenosis].

Authors:  H-J Busch; I Buschmann; E Schneeloch; C Bode; G Mies; K-A Hossmann
Journal:  Nervenarzt       Date:  2006-02       Impact factor: 1.214

4.  Regulation of the pathological vasculature of malignant astrocytomas by angiopoietin-1.

Authors:  Gelareh Zadeh; Rob Reti; Keyvan Koushan; Qian Baoping; Patrick Shannon; Abhijit Guha
Journal:  Neoplasia       Date:  2005-12       Impact factor: 5.715

5.  Restoring transcription factor HoxA5 expression inhibits the growth of experimental hemangiomas in the brain.

Authors:  Yiqian Zhu; Ileana C Cuevas; Rodney Allanigue Gabriel; Hua Su; Stephen Nishimura; Peng Gao; Alexander Fields; Qi Hao; William L Young; Guo-Yuan Yang; Nancy J Boudreau
Journal:  J Neuropathol Exp Neurol       Date:  2009-06       Impact factor: 3.685

6.  In vitro angiogenesis by human umbilical vein endothelial cells (HUVEC) induced by three-dimensional co-culture with glioblastoma cells.

Authors:  Zhijian Chen; Andre Htay; Wagner Dos Santos; George T Gillies; Helen L Fillmore; Milton M Sholley; William C Broaddus
Journal:  J Neurooncol       Date:  2008-11-28       Impact factor: 4.130

Review 7.  GBM's multifaceted landscape: highlighting regional and microenvironmental heterogeneity.

Authors:  Alenoush Vartanian; Sanjay K Singh; Sameer Agnihotri; Shahrzad Jalali; Kelly Burrell; Kenneth D Aldape; Gelareh Zadeh
Journal:  Neuro Oncol       Date:  2014-03-18       Impact factor: 12.300

8.  Effects of minocycline on apoptosis and angiogenesis-related protein expression in a rat model of intracerebral hemorrhage.

Authors:  Ruizhi Wang; Dongning Hao; Wei Shi; Jingnan Pu; Zizhang Wang
Journal:  Neural Regen Res       Date:  2012-03-15       Impact factor: 5.135

9.  Transplantation of human umbilical cord blood mesenchymal stem cells to treat a rat model of traumatic brain injury.

Authors:  Junjian Zhao; Naiyao Chen; Na Shen; Hui Zhao; Dali Wang; Jun Shi; Yang Wang; Xiufeng Cui; Zhenyu Yan; Hui Xue
Journal:  Neural Regen Res       Date:  2012-04-05       Impact factor: 5.135

10.  Intracerebral and Intravenous Transplantation Represents a Favorable Approach for Application of Human Umbilical Cord Mesenchymal Stromal Cells in Intracerebral Hemorrhage Rats.

Authors:  Jiang Xie; Bin Wang; Lian Wang; Fang Dong; Gang Bai; Yongjun Liu
Journal:  Med Sci Monit       Date:  2016-10-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.